Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
GOVX · NASDAQ · Pharmaceutical Preparations
$1.91−0.08 (−4.02%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day, not a live quote
Geovax Labs (GOVX) · oqro.io/stocks/GOVX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Armistice Capital, LLC now owns 10.0% of GOVX as a passive investorSourceInsider trade · Traded Aug 7, 2025 · Filed Aug 8, 2025
Officer purchased ~$742 of GOVX shares in the open marketSourceInsider trade · Traded Apr 10, 2025 · Filed Apr 11, 2025
Director purchased ~$9.8K of GOVX shares in the open marketSourceInsider trade · Traded Apr 10, 2025 · Filed Apr 10, 2025
Officer purchased ~$5.9K of GOVX shares in the open marketSourceInsider trade · Traded Apr 1, 2025 · Filed Apr 1, 2025
CEO purchased ~$11K of GOVX shares in the open marketSourceInsider trade · Traded Mar 31, 2025 · Filed Mar 31, 2025
CFO purchased ~$7.3K of GOVX shares in the open marketSource